Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc. demonstrated a strong financial performance marked by much higher revenue and improved gross margins, which significantly offset increased operating expenses. The company is experiencing a fast-paced build-out of AI infrastructure, resulting in robust growth across its PCIe Gen 6 product offerings, which represented over 20% of total revenue in the third quarter. Looking ahead, Astera Labs has guided for revenue of $249.0 million in the fourth quarter, indicating substantial sequential and year-over-year growth, supported by ongoing demand for AI server shipments and a positive outlook for both its Scorpio and Taurus product lines.

Bears say

Astera Labs Inc faces a challenging outlook as its revenue growth is closely tied to the pace of data center infrastructure spending, which can be significantly affected by macroeconomic fluctuations and a potential slowdown in capital investments. The company's reliance on specific markets, particularly in the United States, may expose it to risks associated with geographic economic variability. Furthermore, the dependence on a concentrated customer base among hyperscalers and system OEMs adds another layer of vulnerability to its financial performance.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Apr 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $197.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $197.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.